Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- The Institute for Therapeutic Discovery Licenses Respiratory Health Product to Allergy Research Group
Allergy Research Group will market "Mucolyxir" DNA-based nutritional supplement to health professionals and to retail outlets.
- The Institute for Therapeutic Discovery Licenses Respiratory Health Product to Allergy Research Group
Allergy Research Group will market "Mucolyxir" DNA-based nutritional supplement to health professionals and to retail outlets.
- The Institute for Therapeutic Discovery Licenses Respiratory Health Product to Allergy Research Group
Allergy Research Group will market "Mucolyxir" DNA-based nutritional supplement to health professionals and to retail outlets.
- The Institute for Therapeutic Discovery Licenses Respiratory Health Product to Allergy Research Group
Allergy Research Group will market "Mucolyxir" DNA-based nutritional supplement to health professionals and to retail outlets.
- The Institute for Therapeutic Discovery Licenses Respiratory Health Product to Allergy Research Group
Allergy Research Group will market "Mucolyxir" DNA-based nutritional supplement to health professionals and to retail outlets.
- The Institute for Therapeutic Discovery Licenses Respiratory Health Product to Allergy Research Group
Allergy Research Group will market "Mucolyxir" DNA-based nutritional supplement to health professionals and to retail outlets.
- The Institute for Therapeutic Discovery Licenses Respiratory Health Product to Allergy Research Group
Allergy Research Group will market "Mucolyxir" DNA-based nutritional supplement to health professionals and to retail outlets.
- HORMOS Licenses HMRlignan(TM) to LINNEA
Companies sign world-wide license agreement for HMRligna(TM), a plant lignan, 7-hydroxymatairesinol, isolated and purified from Norway spruce (picea abies); Linnea to provide manufacturing and marketing .
- HORMOS Licenses HMRlignan(TM) to LINNEA
Companies sign world-wide license agreement for HMRligna(TM), a plant lignan, 7-hydroxymatairesinol, isolated and purified from Norway spruce (picea abies); Linnea to provide manufacturing and marketing .
- HORMOS Licenses HMRlignan(TM) to LINNEA
Companies sign world-wide license agreement for HMRligna(TM), a plant lignan, 7-hydroxymatairesinol, isolated and purified from Norway spruce (picea abies); Linnea to provide manufacturing and marketing .
- HORMOS Licenses HMRlignan(TM) to LINNEA
Companies sign world-wide license agreement for HMRligna(TM), a plant lignan, 7-hydroxymatairesinol, isolated and purified from Norway spruce (picea abies); Linnea to provide manufacturing and marketing .
- HORMOS Licenses HMRlignan(TM) to LINNEA
Companies sign world-wide license agreement for HMRligna(TM), a plant lignan, 7-hydroxymatairesinol, isolated and purified from Norway spruce (picea abies); Linnea to provide manufacturing and marketing .
- HORMOS Licenses HMRlignan(TM) to LINNEA
Companies sign world-wide license agreement for HMRligna(TM), a plant lignan, 7-hydroxymatairesinol, isolated and purified from Norway spruce (picea abies); Linnea to provide manufacturing and marketing .
- HORMOS Licenses HMRlignan(TM) to LINNEA
Companies sign world-wide license agreement for HMRligna(TM), a plant lignan, 7-hydroxymatairesinol, isolated and purified from Norway spruce (picea abies); Linnea to provide manufacturing and marketing .
- Phytomedics Inc. Licenses Novel Anti-Inflammatory Compound Intellectual Property from Louisiana State University System
Company announces that it has become the exclusive licensee of U.S. patent #5,905,089, entitled "Use of sesquiterpene lactones for treatment of severe inflammatory disorders."
- Phytomedics Inc. Licenses Novel Anti-Inflammatory Compound Intellectual Property from Louisiana State University System
Company announces that it has become the exclusive licensee of U.S. patent #5,905,089, entitled "Use of sesquiterpene lactones for treatment of severe inflammatory disorders."
- Phytomedics Inc. Licenses Novel Anti-Inflammatory Compound Intellectual Property from Louisiana State University System
Company announces that it has become the exclusive licensee of U.S. patent #5,905,089, entitled "Use of sesquiterpene lactones for treatment of severe inflammatory disorders."
- Phytomedics Inc. Licenses Novel Anti-Inflammatory Compound Intellectual Property from Louisiana State University System
Company announces that it has become the exclusive licensee of U.S. patent #5,905,089, entitled "Use of sesquiterpene lactones for treatment of severe inflammatory disorders."
- Phytomedics Inc. Licenses Novel Anti-Inflammatory Compound Intellectual Property from Louisiana State University System
Company announces that it has become the exclusive licensee of U.S. patent #5,905,089, entitled "Use of sesquiterpene lactones for treatment of severe inflammatory disorders."
- Martek Signs Two New Infant Formula Licensees
Company announces that that infant formula companies Pasteur Milk Co., Ltd. and Semper AB have signed license agreements for use of Martek's docosahexaenoic acid and arachidonic acid in infant formula. Pasteur's license covers South Korea and Semper's license includes Finland, Sweden, Latvia and Lithuania.
- Martek Signs Two New Infant Formula Licensees
Company announces that that infant formula companies Pasteur Milk Co., Ltd. and Semper AB have signed license agreements for use of Martek's docosahexaenoic acid and arachidonic acid in infant formula. Pasteur's license covers South Korea and Semper's license includes Finland, Sweden, Latvia and Lithuania.
- Martek Signs Two New Infant Formula Licensees
Company announces that that infant formula companies Pasteur Milk Co., Ltd. and Semper AB have signed license agreements for use of Martek's docosahexaenoic acid and arachidonic acid in infant formula. Pasteur's license covers South Korea and Semper's license includes Finland, Sweden, Latvia and Lithuania.
- Martek Signs Two New Infant Formula Licensees
Company announces that that infant formula companies Pasteur Milk Co., Ltd. and Semper AB have signed license agreements for use of Martek's docosahexaenoic acid and arachidonic acid in infant formula. Pasteur's license covers South Korea and Semper's license includes Finland, Sweden, Latvia and Lithuania.
- Martek Signs Two New Infant Formula Licensees
Company announces that that infant formula companies Pasteur Milk Co., Ltd. and Semper AB have signed license agreements for use of Martek's docosahexaenoic acid and arachidonic acid in infant formula. Pasteur's license covers South Korea and Semper's license includes Finland, Sweden, Latvia and Lithuania.
- Imagenetix Licenses Patent Related to Body Fat Control
Company has announced that it has signed a license agreement with the University of Minnesota for the exclusive rights to the University's recently awarded patent covering a natural compound for lowering the body's levels of leptin, a circulating hormone that regulates fat storage.
- Imagenetix Licenses Patent Related to Body Fat Control
Company has announced that it has signed a license agreement with the University of Minnesota for the exclusive rights to the University's recently awarded patent covering a natural compound for lowering the body's levels of leptin, a circulating hormone that regulates fat storage.
- Imagenetix Licenses Patent Related to Body Fat Control
Company has announced that it has signed a license agreement with the University of Minnesota for the exclusive rights to the University's recently awarded patent covering a natural compound for lowering the body's levels of leptin, a circulating hormone that regulates fat storage.
- Imagenetix Licenses Patent Related to Body Fat Control
Company has announced that it has signed a license agreement with the University of Minnesota for the exclusive rights to the University's recently awarded patent covering a natural compound for lowering the body's levels of leptin, a circulating hormone that regulates fat storage.
- Imagenetix Licenses Patent Related to Body Fat Control
Company has announced that it has signed a license agreement with the University of Minnesota for the exclusive rights to the University's recently awarded patent covering a natural compound for lowering the body's levels of leptin, a circulating hormone that regulates fat storage.
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- IdeaSphere Obtains Exclusive Worldwide License** to Weil Nutritional Supplements
Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada).
- Gold’s Gym International Announces Exclusive Sports Nutrition License With Performance Edge
Gold’s Gym International has entered into a licensing agreement with Performance Edge Sports Nutrition LLC, a division of Futurebiotics, to manufacture and market a line of Gold’s Gym-branded sports nutrition products for distribution in Gold’s Gyms and retail outlets.
- Gold’s Gym International Announces Exclusive Sports Nutrition License With Performance Edge
Gold’s Gym International has entered into a licensing agreement with Performance Edge Sports Nutrition LLC, a division of Futurebiotics, to manufacture and market a line of Gold’s Gym-branded sports nutrition products for distribution in Gold’s Gyms and retail outlets.
- Gold’s Gym International Announces Exclusive Sports Nutrition License With Performance Edge
Gold’s Gym International has entered into a licensing agreement with Performance Edge Sports Nutrition LLC, a division of Futurebiotics, to manufacture and market a line of Gold’s Gym-branded sports nutrition products for distribution in Gold’s Gyms and retail outlets.
- Gold’s Gym International Announces Exclusive Sports Nutrition License With Performance Edge
Gold’s Gym International has entered into a licensing agreement with Performance Edge Sports Nutrition LLC, a division of Futurebiotics, to manufacture and market a line of Gold’s Gym-branded sports nutrition products for distribution in Gold’s Gyms and retail outlets.
- Gold’s Gym International Announces Exclusive Sports Nutrition License With Performance Edge
Gold’s Gym International has entered into a licensing agreement with Performance Edge Sports Nutrition LLC, a division of Futurebiotics, to manufacture and market a line of Gold’s Gym-branded sports nutrition products for distribution in Gold’s Gyms and retail outlets.
- Gold’s Gym International Announces Exclusive Sports Nutrition License With Performance Edge
Gold’s Gym International has entered into a licensing agreement with Performance Edge Sports Nutrition LLC, a division of Futurebiotics, to manufacture and market a line of Gold’s Gym-branded sports nutrition products for distribution in Gold’s Gyms and retail outlets.
- Gold’s Gym International Announces Exclusive Sports Nutrition License With Performance Edge
Gold’s Gym International has entered into a licensing agreement with Performance Edge Sports Nutrition LLC, a division of Futurebiotics, to manufacture and market a line of Gold’s Gym-branded sports nutrition products for distribution in Gold’s Gyms and retail outlets.
- Integrated Genomics and DANONE Sign 3-Year ERGO License Deal
The Daniel Carasso Center, Groupe DANONE's Research Center, has entered into a 3-year license for Integrated Genomics’ ERGO® database and genomic discovery system, intend9ng to use the ERGO system as part of its tools to analyze genomic and microarray data from lactic acid bacteria.
- Integrated Genomics and DANONE Sign 3-Year ERGO License Deal
The Daniel Carasso Center, Groupe DANONE's Research Center, has entered into a 3-year license for Integrated Genomics’ ERGO® database and genomic discovery system, intend9ng to use the ERGO system as part of its tools to analyze genomic and microarray data from lactic acid bacteria.
- Integrated Genomics and DANONE Sign 3-Year ERGO License Deal
The Daniel Carasso Center, Groupe DANONE's Research Center, has entered into a 3-year license for Integrated Genomics’ ERGO® database and genomic discovery system, intend9ng to use the ERGO system as part of its tools to analyze genomic and microarray data from lactic acid bacteria.
- Integrated Genomics and DANONE Sign 3-Year ERGO License Deal
The Daniel Carasso Center, Groupe DANONE's Research Center, has entered into a 3-year license for Integrated Genomics’ ERGO® database and genomic discovery system, intend9ng to use the ERGO system as part of its tools to analyze genomic and microarray data from lactic acid bacteria.
- Integrated Genomics and DANONE Sign 3-Year ERGO License Deal
The Daniel Carasso Center, Groupe DANONE's Research Center, has entered into a 3-year license for Integrated Genomics’ ERGO® database and genomic discovery system, intend9ng to use the ERGO system as part of its tools to analyze genomic and microarray data from lactic acid bacteria.
- Integrated Genomics and DANONE Sign 3-Year ERGO License Deal
The Daniel Carasso Center, Groupe DANONE's Research Center, has entered into a 3-year license for Integrated Genomics’ ERGO® database and genomic discovery system, intend9ng to use the ERGO system as part of its tools to analyze genomic and microarray data from lactic acid bacteria.
- Chr. Hansen Awarded Patent on Purification Process of Natural Color
The United States Patent and Trademark Office has issued a patent to Chr. Hansen for the "Purification process for improving total yield of curcuminoid coloring agent" under the patent number 6,942,881.
- Chr. Hansen Awarded Patent on Purification Process of Natural Color
The United States Patent and Trademark Office has issued a patent to Chr. Hansen for the "Purification process for improving total yield of curcuminoid coloring agent" under the patent number 6,942,881.
- Chr. Hansen Awarded Patent on Purification Process of Natural Color
The United States Patent and Trademark Office has issued a patent to Chr. Hansen for the "Purification process for improving total yield of curcuminoid coloring agent" under the patent number 6,942,881.
- Chr. Hansen Awarded Patent on Purification Process of Natural Color
The United States Patent and Trademark Office has issued a patent to Chr. Hansen for the "Purification process for improving total yield of curcuminoid coloring agent" under the patent number 6,942,881.
- Chr. Hansen Awarded Patent on Purification Process of Natural Color
The United States Patent and Trademark Office has issued a patent to Chr. Hansen for the "Purification process for improving total yield of curcuminoid coloring agent" under the patent number 6,942,881.
- Advanced BioNutrition Is Worldwide Licensee of Newly Issued Patent for Production of DHA Issued to University of Hull (GB) and Wageningen University (NL)
Company is the worldwide exclusive licensee of a patent (U.S. patent (#6,977,166)) issued to the University of Hull (GB) and the Agrotechnology & Food Sciences Group (AFSG) of Wageningen University and Research Centre entitled "Method of Producing an Oil Including Docosahexaenoic Acid," and describing a novel method for producing an oil containing docosahexaenoic acid (DHA) by fermentation of the microalgae Crypthecodinium cohnii.
- Advanced BioNutrition Is Worldwide Licensee of Newly Issued Patent for Production of DHA Issued to University of Hull (GB) and Wageningen University (NL)
Company is the worldwide exclusive licensee of a patent (U.S. patent (#6,977,166)) issued to the University of Hull (GB) and the Agrotechnology & Food Sciences Group (AFSG) of Wageningen University and Research Centre entitled "Method of Producing an Oil Including Docosahexaenoic Acid," and describing a novel method for producing an oil containing docosahexaenoic acid (DHA) by fermentation of the microalgae Crypthecodinium cohnii.
- Advanced BioNutrition Is Worldwide Licensee of Newly Issued Patent for Production of DHA Issued to University of Hull (GB) and Wageningen University (NL)
Company is the worldwide exclusive licensee of a patent (U.S. patent (#6,977,166)) issued to the University of Hull (GB) and the Agrotechnology & Food Sciences Group (AFSG) of Wageningen University and Research Centre entitled "Method of Producing an Oil Including Docosahexaenoic Acid," and describing a novel method for producing an oil containing docosahexaenoic acid (DHA) by fermentation of the microalgae Crypthecodinium cohnii.
- NeoCell Corporation Files for Patent Protection on Canine and Equine Collagen Joint Health Supplement
Company announces the filing of patent protection on ArthroPet(TM), made with kolla2®.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
SOLVAY PHARMACEUTICALS and PRONOVA BIOCARE (Norway) announce today the signing of an additional license and supply agreement for OMACOR®, a product indicated for the secondary prevention after myocardial infarction (MI) and hypertriglyceridemia. This agreement complements Solvay Pharmaceuticals’ Cardiology product portfolio in Asia and New Zealand. Cardiovascular mortality and morbidity are major causes of health concern, and increase as populations age.
Solvay Pharmaceuticals acquires the exclusive distribution rights for India, Pakistan, Sri Lanka, Thailand, Vietnam, Singapore, Malaysia, China, Hong-Kong and New Zealand. This is a major territorial expansion in addition to Solvay’s current OMACOR® franchise in e.g. greater Europe and the Middle East. Solvay Pharmaceuticals will take over the active registration in Thailand and submit registration files for the indications secondary prevention post-MI and hypertriglyceridemia in the other countries.
OMACOR® contains highly purified omega-3-acid ethyl esters. The product is registered by Pronova / Solvay Pharmaceuticals in more than 30 countries for adjuvant treatment in secondary prevention after myocardial infarction and for treatment of increased blood triglyceride levels or hypertriglyceridemia.
OMACOR® is part of the Solvay Pharmaceuticals’ cardiology product portfolio, which also includes the anti-hypertensives, TEVETEN® (eprosartan), PHYSIOTENS® (moxonidine) and the lipid lowering agent LIPHANTHYL® (fenofibrate), which was recently added to Solvay’s cardiology portfolio through the acquisition of Fournier Pharma.
SOLVAY is an international chemical and pharmaceutical group with headquarters in Brussels. It employs some 33,000 people (with Fournier Pharma) in 50 countries. In 2004 its consolidated pro forma sales amounted to EUR 8.5 billion generated by its three activity sectors : Chemicals, Plastics and Pharmaceuticals. Solvay is listed on the Euronext 100 index of top European companies. Details are available at www.solvay.com.
SOLVAY PHARMACEUTICALS is the pharmaceuticals entity of Solvay. It is a research driven pharmaceutical company that seeks to fulfill carefully selected, unmet medical needs in the therapeutic areas of cardiology, gastroenterology, mental health and gynecology/andrology. Solvay Pharmaceuticals employs about 13,000 people worldwide (with Fournier Pharma).
PRONOVA BIOCARE is a world leader in Omega-3 fatty acids. The active ingredients of OMACOR® are processed at Pronova’s plant in Sandefjord / Norway. The production process is patented all over the world. More information is available from the website www.pronovabiocare.com |